New York State Reports Cases of Pediatric Inflammatory Syndrome Tied to COVID-19
Pediatric patients presenting with compatible symptoms should undergo SARS-CoV-2 testing
RHB-105 Effective for Eradication of Helicobacter pylori in Adults
Eradication rates with triple therapy unaffected by resistance to clarithromycin, metronidazole
GI Symptoms Seen in Less Than 10 Percent of COVID-19 Patients
Outpatients with new-onset GI symptoms should be monitored for COVID-19 symptoms
Health Insurance Coverage Disruption Impedes Cancer Care
Findings consistent across cancer continuum, from screening to treatment and end-of-life care
High Clinical Burden Associated With Nonalcoholic Fatty Liver Disease
Prevalence of NAFLD was 5.7 percent, with cumulative risk for mortality of 12.6 percent for NAFLD
USPSTF Recommends Hep B Screening for Those at Increased Risk
Screening for HBV has moderate net benefit in adolescents, adults at increased risk for infection
Recommendations Made for PPE Use by HCPs in COVID-19 Care
Guidelines address mask, glove, face shield use in conventional, contingency, crisis capacity settings
ATS Issues Guideline on the Diagnosis of Sarcoidosis
Recommendations address the uncertainties faced by clinicians in the detection, diagnosis of sarcoidosis
Guidelines Issued for Managing Eosinophilic Esophagitis
Topical glucocorticosteroids recommended over no treatment
American Association for Cancer Research, April 27-28
The American Association for Cancer Research Annual Meeting 2020 The annual meeting of the American Association for Cancer Research was held virtually this...
